Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751309 · ClinicalTrials.gov registry record
Lung Allograft Rejection Gene Expression Observational (LARGO) Study
A clinical trial, sponsored by XDx.
- Terminated
- Registry status
- 2,044
- Enrollment target
NCT00751309 is a clinical trial that was terminated before completion, run by XDx. The registered enrollment target is 2,044 participants.
The verdict
NCT00751309 was terminated before completion, sponsored by XDx.
- TERMINATED
- Registry status
- 2,044 participants
- Enrollment target
Study Summary
The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular analyses in association with the study endpoints. The primary objective is to use gene expression profiling of peripheral blood mononuclear cells to differentiate between the absence and presence of acute cellular rejection. The secondary objectives are to use other genomic and proteomic technologies to analyze RNA and protein in blood samples in relation to related clinical conditions. The overall goal is to apply novel molecular insights in the development of non-invasive molecular diagnostic tests for lung transplantation.
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,044 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00751309
The ClinicalTrials.gov registry entry for NCT00751309 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2,044 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is XDx, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT00751309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00751309 about?
NCT00751309 is a clinical study titled "Lung Allograft Rejection Gene Expression Observational (LARGO) Study". The objective of the LARGO Study protocol is to collect peripheral blood samples, select associated lung biopsy pathology slides, and clinical data from lung transplant recipients to perform molecular analyses in association with the study endpoints. The primary objective is to use gene expression p...
What is the current status of trial NCT00751309?
This trial is currently terminated. The enrollment target is 2,044 participants. The study started on 2004-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00751309?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT00751309?
This trial is sponsored by XDx, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.